7128-32-7

Usage

Core structure

Tetrahydropyrido[4,3-d]pyrimidine
A central pyrimidine ring with four carbon atoms and two nitrogen atoms, fused with a six-membered tetrahydro ring containing one oxygen atom and five carbon atoms.

Additional heterocyclic rings

Morpholine and pyrrolidine

Morpholine

A five-membered heterocyclic ring with four carbon atoms and one nitrogen atom, featuring oxygen atoms at each carbon.

Pyrrolidine

A five-membered heterocyclic ring with four carbon atoms and one nitrogen atom, without any additional substituents.

Substituents

2-(morpholin-4-yl), 6-propyl, and 4-(pyrrolidin-1-yl)

2-(Morpholin-4-yl)

A morpholine ring attached to the second carbon of the tetrahydropyrido[4,3-d]pyrimidine core.

6-Propyl

A propyl group (three-carbon alkyl chain) attached to the sixth carbon of the tetrahydropyrido[4,3-d]pyrimidine core.

4-(Pyrrolidin-1-yl)

A pyrrolidine ring attached to the fourth carbon of the tetrahydropyrido[4,3-d]pyrimidine core.

Potential pharmaceutical applications

Interaction with various biological targets
The compound's complex structure allows it to potentially interact with multiple biological targets, making it a candidate for therapeutic agent development.

Promising candidate for pharmacological exploration

The presence of multiple heterocyclic rings in its structure makes it a promising candidate for further research into its pharmacological properties and potential drug development.

Need for further research

Pharmacological effects and potential uses
More research is required to fully understand the compound's pharmacological effects and potential applications in drug development.